- Home
- ADCT vs SNDL Comparison
ADCT vs SNDL Comparison
Compare ADCT & SNDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- SNDL
- Stock Information
- Founded
- ADCT 2011
- SNDL 2006
- Country
- ADCT Switzerland
- SNDL Canada
- Employees
- ADCT N/A
- SNDL N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- SNDL Pharmaceuticals and Biotechnology
- Sector
- ADCT Health Care
- SNDL Health Care
- Exchange
- ADCT Nasdaq
- SNDL Nasdaq
- Market Cap
- ADCT 454.5M
- SNDL 432.6M
- IPO Year
- ADCT 2020
- SNDL 2019
- Fundamental
- Price
- ADCT $4.40
- SNDL $1.76
- Analyst Decision
- ADCT Strong Buy
- SNDL Strong Buy
- Analyst Count
- ADCT 6
- SNDL 1
- Target Price
- ADCT $7.60
- SNDL $5.00
- AVG Volume (30 Days)
- ADCT 759.6K
- SNDL 2.4M
- Earning Date
- ADCT 11-10-2025
- SNDL 11-04-2025
- Dividend Yield
- ADCT N/A
- SNDL N/A
- EPS Growth
- ADCT N/A
- SNDL N/A
- EPS
- ADCT N/A
- SNDL N/A
- Revenue
- ADCT $75,209,000.00
- SNDL $683,170,243.00
- Revenue This Year
- ADCT $11.78
- SNDL $5.30
- Revenue Next Year
- ADCT $4.83
- SNDL $4.11
- P/E Ratio
- ADCT N/A
- SNDL N/A
- Revenue Growth
- ADCT 6.35
- SNDL 4.43
- 52 Week Low
- ADCT $1.05
- SNDL $1.15
- 52 Week High
- ADCT $4.80
- SNDL $2.89
- Technical
- Relative Strength Index (RSI)
- ADCT 58.45
- SNDL 39.87
- Support Level
- ADCT $3.95
- SNDL $1.57
- Resistance Level
- ADCT $4.29
- SNDL $1.79
- Average True Range (ATR)
- ADCT 0.28
- SNDL 0.08
- MACD
- ADCT 0.03
- SNDL 0.02
- Stochastic Oscillator
- ADCT 89.02
- SNDL 54.25
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About SNDL SNDL Inc.
SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.